Trial Profile
RANDOMISED CONTROLLED TRIAL OF BOTULINUM TOXIN TYPE A AND B EFFICACY IN REDUCING DROOLING IN PARKINSON DISEASE
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jun 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Botulinum toxin B
- Indications Parkinson's disease
- Focus Therapeutic Use
- 29 Jun 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 22 Mar 2012 New trial record